FDA has approved Daiichi Sankyo's AZOR (amlodipine and olmesartan medoxomil) for the treatment of hypertension, also known as high blood pressure. AZOR is a convenient, once daily, single tablet combination of amlodipine, the number one prescribed calcium channel blocker (CCB) on the market, and olmesartan medoxomil, the active ingredient in Benicar, which is the fastest growing angiotensin receptor blocker (ARB).
Ads by Google
National Alliance for Hispanic Health is launching a new national program called Hypertension ... Control is in your Hands.
Nebivolol, a selective beta 1-blocker with vasodilating properties, significantly reduced sitting diastolic and systolic blood pressure among patients with mild-to-moderate hypertension.
Blood pressure is oftent not properly diagnosed in children and adolescents. In a study of children and adolescents with hypertension, only about one in four had been previously diagnosed with the condition.
The distrust of healthcare providers shown by people with high blood pressure impedes effective treatment.
Substituting soy nuts for other protein sources in a healthy diet appears to lower blood pressure in postmenopausal women, and also may reduce cholesterol levels in women with high blood pressure.
Single tablets containing two drugs may be the key to increasing blood pressure control rates from 36 percent to over 80 percent in the U.S.
Fixed-dose combination BENICAR HCT was associated with a greater mean reduction in seated systolic blood pressure at 12 weeks in patients with Stage 2 hypertension, compared with amlodipine + benazepril study doses.
While men and women both get high blood pressure and related kidney disease, the path to get there is shorter, steeper and just different for men.
High blood pressure is known among doctors and medical professionals as a "silent killer." Nearly one in three adults in the U.S. has high blood pressure but shows no symptoms of this potentially lethal condition.